A new therapy that first made headlines in 2021 is now showing potential to heal human cartilage. Developed by scientists at ...

[19] Potentially important platelet mediators include platelet-derived growth factor (PDGF), TGF-beta 1, and epidermal growth factor (EGF). Fibrogenesis. Increased matrix production is the most ...

New research links multisystem inflammatory syndrome in children with COVID-19 to Epstein-Barr virus reactivation, revealing ...

The study reexamined immunotherapy clinical trial data on bladder and skin cancer and found that "cold" tumors, ones that haven't yet been infiltrated by immune cells, are just as ...

Both STP705 and STP707 are made of two siRNA oligonucleotides that hit transforming growth factor beta 1 (TGF-β1) and cyclooxygenase 2 (COX-2) mRNA, gatekeeper targets for oncology and fibrosis.

Keros Therapeutics, Inc. (“Keros”) (Nasdaq: KROS), a clinical-stage biopharmaceutical company focused on developing and commercializing novel therapeutics to treat a wide range of patients with ...

Immune responses, including chemokine secretion (TNF-alpha and IL8) and gene-expression (RT-PCR) (IL6, IL8 and TGF-beta) were studied at different time points for characterization of changes in ...